Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction
Open Access
- 1 December 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (51), 35839-35849
- https://doi.org/10.1074/jbc.m109.057273
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in MiceHypertension, 2008
- Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and AktPublished by Elsevier BV ,2008
- Remodelling of gap junctions and connexin expression in diseased myocardiumCardiovascular Research, 2008
- Cyclooxygenase‐2 induction by adiponectin is regulated by a sphingosine kinase‐1 dependent mechanism in cardiac myocytesFEBS Letters, 2008
- A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathwayProceedings of the National Academy of Sciences of the United States of America, 2006
- Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3Molecular and Cellular Biology, 2006
- AMPK alterations in cardiac physiology and pathology: enemy or ally?The Journal of Physiology, 2006
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failureJCI Insight, 2005
- Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contractionThe EMBO Journal, 2005
- Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinaseNature Genetics, 1998